SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer
Cell Reports · 2026-06 · 45 (6) · 117387
DOI: 10.1016/j.celrep.2026.117387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-06. Verfasst von Nivedeta Krishna Kumar und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Organic Cation Transporter 3, Pancreatic Neoplasms, Serotonin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH NIGMS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Genetics Cell Biology & Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.
- Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center at Omaha, Omaha, NE, USA; Department of Genetics Cell Biology & Anatomy, Universi…
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of…
- Department of Pathology, Microbiology & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIH NIGMS
- University of Nottingham Malaysia Campus
- National Institutes of Health
Zitieren
APA
Krishna Kumar, N., Varadharaj, V., Gayen, N., Kaur, A. B., Arikath, K., Shah, A., Mathivanan, P., Nallasamy, P., Alsafwani, Z. W., Seshadri, B., Raut, P., Rauth, S., Persinger, J., Brahma, S., Schott, M., Oberley-Deegan, R. E., Talmon, G. A., Cox, J. L., Batra, S. K., & Ponnusamy, M. P. (2026). SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. Cell Reports, 45(6), 117387. https://doi.org/10.1016/j.celrep.2026.117387
Vancouver
Krishna Kumar N, Varadharaj V, Gayen N, Kaur AB, Arikath K, Shah A, et al. SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. Cell Reports. 2026;45(6):117387. doi:10.1016/j.celrep.2026.117387
BibTeX
@article{KrishnaKumar2026,
author = {Krishna Kumar, Nivedeta and Varadharaj, Venkatesh and Gayen, Neelanjana and Kaur, Annant Bir and Arikath, Kirtana and Shah, Ashu and Mathivanan, Poompozhil and Nallasamy, Palanisamy and Alsafwani, Zahraa Wajih and Seshadri, Bhuvaneshwari and Raut, Pratima and Rauth, Sanchita and Persinger, Jimmie and Brahma, Sandipan and Schott, Micah and Oberley-Deegan, Rebecca E and Talmon, Geoffrey A and Cox, Jesse L and Batra, Surinder K and Ponnusamy, Moorthy P},
title = {SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {6},
pages = {117387},
doi = {10.1016/j.celrep.2026.117387}
}
EUVIMED